Friday, February 24, 2023

 12:30 PM - 2:00 PM

 Boulevard Auditorium

A/Prof Bridget Barber 

A/Prof. Bridget Barber is an Infectious Diseases Physician at Royal Brisbane & Women’s Hospital, Senior Research Fellow at QIMR Berghofer Medical Research Institute, and NHMRC Investigator Grant EL 2 awardee. She completed her PhD in 2014 at Menzies School of Health Research, with a focus on the emerging zoonotic malaria parasite Plasmodium knowlesi. At QIMR Berghofer she now leads a team conducting malaria volunteer infection studies to evaluate new antimalarials. She co-chairs the COVID-19 Drug Treatment Panel, and the MPX Panel, of the National Clinical Evidence Taskforce. 

A/Prof Krispin Hajkowicz 

A/Prof Krispin Hajkowicz is a Senior Staff Specialist in Infectious Diseases, the former Director of the Infectious Diseases Unit at RBWH for 6 years and a senior staff specialist in the Herston Infectious Diseases Institute. He is currently studying a PhD at the University of Sydney. He was on the frontline of Queensland’s response to the COVID-19 pandemic for more than two years, and founded the Queensland Adult Specialist Immunisation Service in 2021. 

Dr James Pollard 

Dr James Pollard is an Infectious Diseases Physician, Chair of Infection Prevention and Control, and Clinical Director of Community Care at Cabrini Health, a large private hospital group in Melbourne, Australia. James has had a career long passion for extending acute care into the community, with particular focus on IV antibiotics and OPAT, and decentralised healthcare more broadly. He has other interests in HIV, Viral Hepatitis and healthcare design. James has lead Cabrini’s response to COVID outbreaks, including rapidly commissioning a dedicated hospital site for intake and care of covid positive nursing home patients in mid 2020.

Dr David Paterson 

David Paterson is a tenured Professor of Medicine at the Saw Swee Hock School of Public Health and the Yong Loo Lin School of Medicine, both at the National University of Singapore. He is also an Honorary Professor at the University of Queensland. Professor Paterson directs ADVANCE-ID (ADVANcing Clinical Evidence for Infectious Diseases), a clinical trials network comprising more than 40 hospitals across Asia. This network is jointly funded by the Wellcome Trust and a number of Singaporean institutions with an aim to conduct clinically important trials in the field of antimicrobial resistance (AMR). This comprises trials of antibiotics, diagnostics and prevention strategies. 

MSD 

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases.